Back to GetFilings.com



Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

     [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended April 4, 2004 or

     [   ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _________ to _________

Commission File Number 0-17869

COGNEX CORPORATION


(Exact name of registrant as specified in its charter)
     
Massachusetts   04-2713778

 
 
 
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

One Vision Drive
Natick, Massachusetts 01760-2059
(508) 650-3000


(Address, including zip code, and telephone number,
including area code, of principal executive offices)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

         
 
Yes [X] No [   ]

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act)

         
 
Yes [X] No [   ]

     As of May 2, 2004, there were 45,220,758 shares of Common Stock, $.002 par value, of the registrant outstanding.



 


INDEX

             
  FINANCIAL INFORMATION     1  
  Financial Statements     1  
 
  Consolidated Statements of Operations for the three-month periods ended April 4, 2004 and March 30, 2003     1  
 
  Consolidated Balance Sheets at April 4, 2004 and December 31, 2003     2  
 
  Consolidated Statement of Stockholders’ Equity for the three-month period ended April 4, 2004     3  
 
  Consolidated Condensed Statements of Cash Flows for the three-month periods ended April 4, 2004 and March 30, 2003     4  
 
  Notes to Consolidated Financial Statements     5  
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     14  
  Quantitative and Qualitative Disclosures About Market Risk     17  
  Controls and Procedures     17  
  OTHER INFORMATION     18  
  Legal Proceedings     18  
  Changes in Securities and Use of Proceeds     18  
  Defaults Upon Senior Securities     18  
  Submission of Matters to a Vote of Security Holders     18  
  Other Information     18  
  Exhibits and Reports on Form 8-K     18  
 
  Signatures     19  
 Ex-31.1 CEO Certification
 Ex-31.2 CFO Certification
 Ex-32.1 CEO Certification pursuant to Sec. 906
 Ex-32.2 CFO Certification pursuant to Sec. 906

 


Table of Contents

PART I: FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

COGNEX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)
                 
    Three Months Ended
    April 4,   March 30,
    2004
  2003
    (unaudited)
Revenue
               
Product
  $ 42,560     $ 28,248  
Service
    5,609       4,640  
 
   
 
     
 
 
 
    48,169       32,888  
Cost of revenue
               
Product
    11,333       8,870  
Service
    3,456       2,846  
 
   
 
     
 
 
 
    14,789       11,716  
Gross margin
               
Product
    31,227       19,378  
Service
    2,153       1,794  
 
   
 
     
 
 
 
    33,380       21,172  
Research, development, and engineering expenses
    6,898       5,983  
Selling, general, and administrative expenses
    16,314       13,244  
 
   
 
     
 
 
Operating income
    10,168       1,945  
Foreign currency gain (loss)
    625       (627 )
Investment and other income
    1,274       1,294  
 
   
 
     
 
 
Income before provision for income taxes
    12,067       2,612  
Income tax provision
    3,500       819  
 
   
 
     
 
 
Net income
  $ 8,567     $ 1,793  
 
   
 
     
 
 
Net income per common and common-equivalent share:
               
Basic
  $ 0.19     $ 0.04  
 
   
 
     
 
 
Diluted
  $ 0.18     $ 0.04  
 
   
 
     
 
 
Weighted-average common and common-equivalent shares outstanding:
               
Basic
    44,512       42,666  
 
   
 
     
 
 
Diluted
    46,752       43,557  
 
   
 
     
 
 
Cash dividends per common share
  $ 0.06     $  
 
   
 
     
 
 

The accompanying notes are an integral part of these consolidated financial statements.

1


Table of Contents

COGNEX CORPORATION

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)
                 
    April 4,   December 31,
    2004
  2003
    (unaudited)        
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 105,982     $ 76,227  
Short-term investments
    80,752       56,406  
Accounts receivable, less reserves of $2,615 and $2,613 in 2004 and 2003, respectively
    26,456       26,697  
Inventories
    14,221       15,519  
Deferred income taxes
    8,479       8,223  
Prepaid expenses and other current assets
    17,758       14,526  
 
   
 
     
 
 
Total current assets
    253,648       197,598  
Long-term investments
    147,925       170,869  
Property, plant, and equipment, net
    24,500       24,980  
Deferred income taxes
    19,374       19,428  
Intangible assets, net
    7,960       8,582  
Goodwill, net
    6,447       7,222  
Other assets
    3,867       3,854  
 
   
 
     
 
 
 
  $ 463,721     $ 432,533  
 
   
 
     
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
  $ 5,538     $ 5,555  
Accrued expenses
    32,750       32,098  
Customer deposits
    2,641       3,932  
Deferred revenue
    6,028       5,702  
 
   
 
     
 
 
Total current liabilities
    46,957       47,287  
Other liabilities
    243       252  
Commitments (Notes 3, 7, 8, and 9)
               
Stockholders’ equity:
               
Common stock, $.002 par value –
               
Authorized: 140,000 shares, issued: 49,239 and 48,186 shares in 2004 and 2003, respectively
    98       96  
Additional paid-in capital
    234,353       209,679  
Treasury stock, at cost, 4,263 and 4,253 shares in 2004 and 2003, respectively
    (72,765 )     (72,445 )
Retained earnings
    264,615       258,724  
Accumulated other comprehensive loss
    (9,780 )     (11,060 )
 
   
 
     
 
 
Total stockholders’ equity
    416,521       384,994  
 
   
 
     
 
 
 
  $ 463,721     $ 432,533  
 
   
 
     
 
 

The accompanying notes are an integral part of these consolidated financial statements.

2


Table of Contents

COGNEX CORPORATION

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
(In thousands)
                                         
                         
    Common Stock
  Additional
Paid-in
  Treasury Stock
    Shares
  Par Value
  Capital
  Shares
  Cost
Balance at December 31, 2003
    48,186     $ 96     $ 209,679       4,253     $ (72,445 )
Issuance of stock under stock option, stock purchase, and other plans
    1,053       2       20,725       10       (320 )
Tax benefit from exercise of stock options
                    3,949                  
Comprehensive income:
                                       
Net income
                                       
Payment of dividends
                                       
Losses on foreign intercompany loans, net of gains on currency swaps, net of tax of $434
                                       
Net unrealized gain on available-for-sale investments, net of tax of $106
                                       
Foreign currency translation adjustment
                                       
Comprehensive income
                                       
 
   
 
     
 
     
 
     
 
     
 
 
Balance at April 4, 2004 (unaudited)
    49,239     $ 98     $ 234,353       4,263     $ (72,765 )
 
   
 
     
 
     
 
     
 
     
 
 

     

[Additional columns below]

[Continued from above table, first column(s) repeated]

                                 
            Accumulated            
            Other           Total
    Retained   Comprehensive   Comprehensive   Stockholders’
    Earnings
  Loss
  Income
  Equity
Balance at December 31, 2003
  $ 258,724     $ (11,060 )           $ 384,994  
Issuance of stock under stock option, stock purchase, and other plans
                            20,407  
Tax benefit from exercise of stock options
                            3,949  
Comprehensive income:
                               
Net income
    8,567             $ 8,567       8,567  
Payment of dividends
    (2,676 )                     (2,676 )
Losses on foreign intercompany loans, net of gains on currency swaps, net of tax of $434
            (739 )     (739 )     (739 )
Net unrealized gain on available-for-sale investments, net of tax of $106
            180       180       180  
Foreign currency translation adjustment
            1,839       1,839       1,839  
 
                   
 
         
Comprehensive income
                  $ 9,847          
 
   
 
     
 
     
 
     
 
 
Balance at April 4, 2004 (unaudited)
  $ 264,615     $ (9,780 )           $ 416,521  
 
   
 
     
 
             
 
 

The accompanying notes are an integral part of these consolidated financial statements.

3


Table of Contents

COGNEX CORPORATION

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)
                 
    Three Months Ended
    April 4,   March 30,
    2004
  2003
    (unaudited)
Cash flows from operating activities:
               
Net income
  $ 8,567     $ 1,793  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    2,566       2,420  
Tax benefit from exercise of stock options
    3,949       270  
Change in current assets and current liabilities
    (821 )     (289 )
Other
    (561 )     650  
 
   
 
     
 
 
Net cash provided by operating activities
    13,700       4,844  
Cash flows from investing activities:
               
Purchase of investments
    (71,993 )     (53,194 )
Maturity and sale of investments
    70,019       37,554  
Purchase of property, plant, and equipment
    (570 )     (561 )
 
   
 
     
 
 
Net cash used in investing activities
    (2,544 )     (16,201 )
Cash flows from financing activities:
               
Payment of dividends
    (2,676 )      
Issuance of stock under stock option, stock purchase, and other plans
    20,407       1,186  
 
   
 
     
 
 
Net cash provided by financing activities
    17,731       1,186  
Effect of foreign exchange rate changes on cash
    868       276  
 
   
 
     
 
 
Net increase (decrease) in cash and cash equivalents
    29,755       (9,895 )
Cash and cash equivalents at beginning of period
    76,227       60,864  
 
   
 
     
 
 
Cash and cash equivalents at end of period
  $ 105,982     $ 50,969  
 
   
 
     
 
 

The accompanying notes are an integral part of these consolidated financial statements.

4


Table of Contents

COGNEX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1: Summary of Significant Accounting Policies

As permitted by the rules of the Securities and Exchange Commission applicable to Quarterly Reports on Form 10-Q, these notes are condensed and do not contain all disclosures required by generally accepted accounting principles. Reference should be made to the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2003.

In the opinion of the management of Cognex Corporation, the accompanying consolidated unaudited financial statements contain all adjustments necessary to present fairly the Company’s financial position at April 4, 2004, and the results of its operations for the three-month periods ended April 4, 2004 and March 30, 2003, and changes in stockholders’ equity and cash flows for the periods presented.

The results disclosed in the Consolidated Statements of Operations for the three-month period ended April 4, 2004 are not necessarily indicative of the results to be expected for the full year. Certain amounts reported in prior periods have been reclassified to be consistent with the current period presentation.

Stock-Based Compensation Plans

The Company recognizes compensation costs using the intrinsic value based method described in Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees.” Net income and net income per share as reported in these consolidated financial statements and on a pro forma basis, as if the fair value based method described in Statement of Financial Accounting Standards No. 123, “Accounting for Stock-Based Compensation,” had been adopted, are as follows (in thousands):

                 
    Three Months Ended
    April 4,   March 30,
    2004
  2003
Net income, as reported
  $ 8,567     $ 1,793  
Less: Total stock-based compensation costs determined under fair value based method, net of tax
    (3,703 )     (3,171 )
 
   
 
     
 
 
Net income (loss), pro forma
  $ 4,864     $ (1,378 )
 
   
 
     
 
 
Basic net income per share, as reported
  $ 0.19     $ 0.04  
Basic net income (loss) per share, pro forma
  $ 0.11     $ (0.03 )
Diluted net income per share, as reported
  $ 0.18     $ 0.04  
Diluted net income (loss) per share, pro forma
  $ 0.11     $ (0.03 )

For the purpose of providing pro forma disclosures, the fair values of stock options granted were estimated using the Black-Scholes option-pricing model with the following weighted-average assumptions:

                 
    Three Months Ended
    April 4,   March 30,
    2004
  2003
Risk-free interest rate
    2.8 %     2.0 %
Expected life (in years)
    3.2       2.4  
Expected volatility
    45 %     59 %
Expected annualized dividend yield
    .69 %      

5


Table of Contents

COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2: New Pronouncements

In January 2003, the Financial Accounting Standards Board (FASB) issued Interpretation No. 46, “Consolidation of Variable Interest Entities,” to expand upon and strengthen existing accounting guidance that addresses when a company should include in its financial statements the assets, liabilities, and activities of another entity. Previously, a company generally included other entities in its consolidated financial statements only if it controlled the entity through voting interests. Interpretation No. 46 changes that guidance by requiring variable interest entities, as defined, to be consolidated by a company if that company is subject to a majority of the risk of loss from the variable interest entity’s activities or is entitled to receive a majority of the entity’s residual returns. Interpretation No. 46 also requires disclosure about variable interest entities that a company is not required to consolidate, but in which it has a significant variable interest. On December 24, 2003, the FASB deferred the effective date of Interpretation No. 46 for certain transactions until periods ending after March 15, 2004. The adoption of Interpretation No. 46 during the quarter ended April 4, 2004 did not have a material impact on the Company’s consolidated financial statements.

The Company has a limited partnership interest in Venrock Associates III, L.P., a venture capital fund and a deposit on certain real estate for which it has an option to purchase. While the Company’s investment in these entities represents a variable interest, the Company believes it is not the primary beneficiary.

NOTE 3: Cash, Cash Equivalents, and Investments

Cash, cash equivalents, and investments consist of the following (in thousands):

                 
    April 4,   December 31,
    2004
  2003
Cash
  $ 85,936     $ 49,980  
Municipal bonds
    20,046       26,247  
 
   
 
     
 
 
Total cash and cash equivalents
    105,982       76,227  
 
   
 
     
 
 
Municipal bonds
    80,752       56,406  
 
   
 
     
 
 
Total short-term investments
    80,752       56,406  
 
   
 
     
 
 
Municipal bonds
    132,687       156,511  
Corporate bonds
    4,188       4,212  
Limited partnership interest
    11,050       10,146  
 
   
 
     
 
 
Total long-term investments
    147,925       170,869  
 
   
 
     
 
 
 
  $ 334,659     $ 303,502  
 
   
 
     
 
 

On June 30, 2000, Cognex Corporation became a Limited Partner in Venrock Associates III, L.P., a venture capital fund. A director of the Company is a Managing General Partner of Venrock Associates. The Company has committed to a total investment in the limited partnership of up to $25,000,000, of which $14,375,000 and $13,625,000 had been contributed as of April 4, 2004 and December 31, 2003, respectively. The commitment to contribute capital expires on January 1, 2005, and the Company does not have the right to withdraw from the partnership prior to December 31, 2010.

During the three-month period ended April 4, 2004, the Company recorded realized gains on the fund’s investments, net of fund expenses, of $154,000. At April 4, 2004, the carrying value of this investment was $11,050,000 compared to an estimated fair value, as determined by the General Partner, of $10,212,000. The unrealized loss of $838,000 was determined to be temporary.

6


Table of Contents

COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4: Inventories

Inventories consist of the following (in thousands):

                 
    April 4,   December 31,
    2004
  2003
Raw materials
  $ 7,727     $ 8,948  
Work-in-process
    4,579       3,514  
Finished goods
    1,915       3,057  
 
   
 
     
 
 
 
  $ 14,221     $ 15,519  
 
   
 
     
 
 

In the fourth quarter of 2001, the Company recorded a $16,300,000 charge in “Cost of product revenue” on the Consolidated Statements of Operations for excess inventories and purchase commitments resulting from an extended slowdown in the semiconductor and electronics industries, as well as the expected transition to newer Cognex hardware platforms by the Company’s OEM customers. A total of $12,500,000 of this charge represented reserves against existing inventories and was accordingly included in “Inventories” on the Consolidated Balance Sheet at December 31, 2001. The remaining $3,800,000 of the charge represented commitments to purchase excess components and systems from various suppliers and accordingly was included in “Accrued Expenses” on the Consolidated Balance Sheet at December 31, 2001.

The following table summarizes the changes in the inventory-related reserves established in the fourth quarter of 2001 (in thousands):

                         
                    Statement of
    Balance Sheet
  Operations
    Inventories
  Accrued Expenses
  Benefits
Reserve balance at December 31, 2003
  $ 9,383     $ 1,400          
 
   
 
     
 
         
Benefits to cost of product revenue recorded in 2003
                  $ 1,290  
 
                   
 
 
Inventory sold to customers
    (216 )         $ 216  
Inventory sold to brokers
    (46 )           46  
Write-off and scrap of inventory
    (59 )            
 
   
 
     
 
     
 
 
Reserve balance at April 4, 2004
  $ 9,062     $ 1,400          
 
   
 
     
 
         
Benefits to cost of product revenue recorded in 2004
                  $ 262  
 
                   
 
 

A favorable settlement of the remaining purchase commitments may result in a recovery of a portion of the remaining $1,400,000 accrued at April 4, 2004.

7


Table of Contents

COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 5: Intangible Assets

Amortized intangible assets consist of the following (in thousands):

                         
    Gross           Net
    Carrying   Accumulated   Carrying
April 4, 2004   Amount
  Amortization
  Amount
                         
Customer contracts and relationships
  $ 7,600     $ 706     $ 6,894  
Complete technology
    5,364       4,417       947  
Patents
    109       22       87  
Non-compete agreements
    48       16       32  
 
   
 
     
 
     
 
 
 
  $ 13,121     $ 5,161     $ 7,960  
 
   
 
     
 
     
 
 
                         
    Gross           Net
    Carrying   Accumulated   Carrying
December 31, 2003   Amount
  Amortization
  Amount
                         
Customer contracts and relationships
  $ 7,832     $ 492     $ 7,340  
Complete technology
    5,388       4,280       1,108  
Patents
    113       17       96  
Non-compete agreements
    50       12       38  
 
   
 
     
 
     
 
 
 
  $ 13,383     $ 4,801     $ 8,582  
 
   
 
     
 
     
 
 

Aggregate amortization expense for the three-month periods ended April 4, 2004 and March 30, 2003 was $383,000 and $102,000, respectively.

Estimated amortization expense for the current fiscal year and succeeding fiscal years is as follows (in thousands):

         
Year
  Amount
2004
  $ 1,510  
2005
    1,204  
2006
    1,085  
2007
    1,033  
2008
    942  
Thereafter
    2,569  
 
   
 
 
Total
  $ 8,343  
 
   
 
 

8


Table of Contents

COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6: Goodwill

The Company has two reporting units with goodwill, the Modular Vision Systems Division (MVSD) and the Surface Inspection Systems Division (SISD), which are also reportable segments.

The changes in the carrying amount of goodwill during the three-month period ended April 4, 2004 are as follows (in thousands):

                         
    MVSD
  SISD
  Consolidated
Balance at December 31, 2003
  $ 4,522     $ 2,700     $ 7,222  
Purchase price adjustment (Note 12)
    (514 )           (514 )
Foreign exchange rate changes
    (165 )     (96 )     (261 )
 
   
 
     
 
     
 
 
Balance at April 4, 2004
  $ 3,843     $ 2,604     $ 6,447  
 
   
 
     
 
     
 
 

NOTE 7: Warranty Obligations

The Company warrants its hardware products to be free from defects in material and workmanship for periods ranging from six months to two years from the time of sale based upon the product being purchased and the terms of the customer’s contract. Estimated warranty obligations are evaluated and recorded at the time of sale based upon historical costs to fulfill warranty obligations. Provisions may also be recorded subsequent to the time of sale whenever specific events or circumstances impacting product quality that would not have been taken into account using historical data become known. Warranty obligations are included in “Accrued expenses” on the Consolidated Balance Sheets.

The changes in the warranty obligation are as follows (in thousands):